Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

Enanta aims to start human trials early next year and Novartis is still testing its pill in animals.
Enanta Chief Executive Jay Luly said re-purposing drugs originally developed for other viral infections is not an unreasonable approach. But it is not known how potent they will be against COVID-19 or how well they can target lung tissue, where the virus takes hold.
The risk is “if it’s not a great effort ...you’ll end up losing time,” Luly said.

That approach led to ENTA's success in anti-Hepatitis C drugs. It also gives me hope that ENTA will have success in drugs to treat RSV, Hepatitis B and or Covid-19. Slow and steady wins the race.